Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,228,368
New position
Shares Held
10,836
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#389
of 854 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HANCOCK WHITNEY CORP holds $38,673,624 across 11 Biotechnology names. INCY ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
330,756 | $17,996,433 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
205,652 | $16,096,381 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
6,649 | $1,602,209 | |
| 4 | INCY |
Incyte Corp
This page
|
10,836 | $1,228,368 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,276 | $633,827 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
792 | $493,843 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
8,677 | $315,928 | |
| 8 | INVA |
Innoviva, Inc.
|
11,967 | $271,769 |
All Filings in INCY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,228,368 | 10,836 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||